Emerging role of bevacizumab in management of patients with symptomatic hepatic involvement in Hereditary Hemorrhagic Telangiectasia

被引:17
作者
Chavan, Ajay [1 ]
Schumann-Binarsch, Silke [2 ]
Schmuck, Bernhard [1 ]
Oltmer, Franziska [3 ]
Geisthoff, Urban [4 ]
Hoppe, Florian [5 ]
Wirsching, Kornelia [6 ]
Klempnauer, Juergen [7 ]
Manns, Michael [8 ]
Thomas, Rohit Philip [1 ]
Koehne, Claus-Henning [2 ]
机构
[1] Klinikum Oldenburg, Dept Diagnost & Intervent Radiol, Rahel Straus Str 10, D-26133 Oldenburg, Germany
[2] Univ Clin Oncol & Haematol, Klinikum Oldenburg, Oldenburg, Germany
[3] Klinikum Oldenburg, Dept Internal Med, Oldenburg, Germany
[4] Essen Univ Hosp, Dept Otorhinolaryngol, Essen, Germany
[5] Klinikum Oldenburg, Dept Otorhinolaryngol, Oldenburg, Germany
[6] Univ Hosp Regensburg, Dept Otorhinolaryngol, Regensburg, Germany
[7] Hannover Med Sch, Dept Visceral & Transplantat Surg, Hannover, Germany
[8] Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, Hannover, Germany
关键词
D O I
10.1002/ajh.24878
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:E641 / E644
页数:4
相关论文
共 6 条
[1]   Complications and clinical outcome of hepatic artery embolisation in patients with hereditary haemorrhagic telangiectasia [J].
Chavan, Ajay ;
Luthe, Lars ;
Gebel, Michael ;
Barg-Hock, Hannelore ;
Seifert, Hans ;
Raab, Rudolph ;
Kirchhoff, Timm ;
Schmuck, B. .
EUROPEAN RADIOLOGY, 2013, 23 (04) :951-957
[2]   Bevacizumab in Patients With Hereditary Hemorrhagic Telangiectasia and Severe Hepatic Vascular Malformations and High Cardiac Output [J].
Dupuis-Girod, Sophie ;
Ginon, Isabelle ;
Saurin, Jean-Christophe ;
Marion, Denis ;
Guillot, Elsa ;
Decullier, Evelyne ;
Roux, Adeline ;
Carette, Marie-France ;
Gilbert-Dussardier, Brigitte ;
Hatron, Pierre-Yves ;
Lacombe, Pascal ;
Lorcerie, Bernard ;
Riviere, Sophie ;
Corre, Romain ;
Giraud, Sophie ;
Bailly, Sabine ;
Paintaud, Gilles ;
Ternant, David ;
Valette, Pierre-Jean ;
Plauchu, Henri ;
Faure, Frederic .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 307 (09) :948-955
[3]   Effect of systemic bevacizumab in severe hereditary hemorrhagic telangiectasia associated with bleeding [J].
Epperla, Narendranath ;
Kapke, Jonathan T. ;
Karafin, Matthew ;
Friedman, Kenneth D. ;
Foy, Patrick .
AMERICAN JOURNAL OF HEMATOLOGY, 2016, 91 (06) :E313-E314
[4]   International guidelines for the diagnosis and management of hereditary haemorrhagic telangiectasia [J].
Faughnan, M. E. ;
Palda, V. A. ;
Garcia-Tsao, G. ;
Geisthoff, U. W. ;
McDonald, J. ;
Proctor, D. D. ;
Spears, J. ;
Brown, D. H. ;
Buscarini, E. ;
Chesnutt, M. S. ;
Cottin, V. ;
Ganguly, A. ;
Gossage, J. R. ;
Guttmacher, A. E. ;
Hyland, R. H. ;
Kennedy, S. J. ;
Korzenik, J. ;
Mager, J. J. ;
Ozanne, A. P. ;
Piccirillo, J. F. ;
Picus, D. ;
Plauchu, H. ;
Porteous, M. E. M. ;
Pyeritz, R. E. ;
Ross, D. A. ;
Sabba, C. ;
Swanson, K. ;
Terry, P. ;
Wallace, M. C. ;
Westermann, C. J. J. ;
White, R. I. ;
Young, L. H. ;
Zarrabeitia, R. .
JOURNAL OF MEDICAL GENETICS, 2011, 48 (02) :73-87
[5]   Liver transplantation for hereditary hemorrhagic telangiectasia -: Report of the European Liver Transplant Registry [J].
Lerut, Jan ;
Orlando, Giuseppe ;
Adam, Rene ;
Sabba, Carlo ;
Pfitzmann, Robert ;
Klempnauer, Jurgen ;
Belghiti, Jacques ;
Pirenne, Jacques ;
Thevenot, Thierry ;
Hillert, Christian ;
Brown, Colin M. ;
Gonze, Dominique ;
Karam, Vincent ;
Boillot, Olivier .
ANNALS OF SURGERY, 2006, 244 (06) :854-864
[6]   Very low dose bevacizumab for the treatment of epistaxis in patients with hereditary hemorrhagic telangiectasia [J].
Thompson, Andrew B. ;
Ross, Douglas A. ;
Berard, Paul ;
Figueroa-Bodine, Jaszmin ;
Livada, Nancy ;
Richer, Sara L. .
ALLERGY & RHINOLOGY, 2014, 5 (02) :E91-E95